Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes is Associated With an Increased Risk of Myocardial Infarction

Nov-09

AUTHORS : Dr Luis A. Garcia Rodríguez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: lagarcia@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : Circulation

REFERENCE: 120(S18):S405

DOI :

Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes is Associated With an Increased Risk of Myocardial Infarction

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Association Between Type 2 Diabetes Onset Age and Risk of Cardiovascular Disease and Mortality: Two Cohort Studies from United Kingdom and Hong Kong